for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Canopy Growth Corp

CGC.OQ

Latest Trade

28.99USD

Change

0.49(+1.72%)

Volume

784,686

Today's Range

27.82

 - 

29.48

52 Week Range

12.95

 - 

56.49

As of on the Toronto Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
28.50
Open
28.50
Volume
784,686
3M AVG Volume
33.78
Today's High
29.48
Today's Low
27.82
52 Week High
56.49
52 Week Low
12.95
Shares Out (MIL)
376.84
Market Cap (MIL)
13,675.53
Forward P/E
-12.04
Dividend (Yield %)
--

Next Event

Q4 2021 Canopy Growth Corp Earnings Release - Tentative

Latest Developments

More

Canopy Growth Expects To Achieve Profitability During Second Half Of FY 2022

Martha Stewart Launches New Line Of CBD Products For Pets

Constellation Brands Qtrly Reported EPS $6.55

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Canopy Growth Corp

Canopy Growth Corp, formerly Tweed Marijuana Inc, is a Canada-based multi-brand cannabis company. The Company, through its subsidiaries Tweed Inc, Bedrocan Canada Inc, Tweed Farms Inc and Mettrum Health Corp is engaged in the business of producing and selling legal marijuana in the Canadian medical market. It is also focusing on producing and selling marijuana in the recreational market in Canada. Its core brands are Tweed and Bedrocan. Tweed is a licensed producer of medical marijuana. Tweed's commercial license covers approximately 168,000 square feet of its Smiths Falls facility and allows Tweed to produce and sell approximately 3,540 kilograms of medical marijuana per year. Tweed's built-out production capacity is over 10 climate controlled indoor growing rooms. Bedrocan is a medical-grade cannabis. Bedrocan's over 52,000 square feet production facility in Toronto, Ontario is licensed, and includes over 30 vegetative and growing rooms, and over three dispensing rooms.

Industry

Biotechnology & Drugs

Contact Info

1 Hershey Dr

SMITHS FALLS, ON

K7A 0A8

Canada

+1.613.5999600

https://www.canopygrowth.com/

Executive Leadership

Judy A. Schmeling

Independent Chairman of the Board

Rade Nikola Kovacevic

President & Chief Product Officer

David Eric Klein

Chief Executive Officer, Director

Mike Lee

Chief Financial Officer, Executive Vice President

Thomas Shipley

Senior Vice President and Chief Science Officer

Key Stats

3.35 mean rating - 17 analysts
Sell
Hold
Buy
Revenue (MM, CAD)

2018

0.1K

2019

0.2K

2020

0.4K

2021(E)

0.6K
EPS (CAD)

2018

-0.400

2019

-2.570

2020

-1.610

2021(E)

-3.015
Price To Earnings (TTM)
--
Price To Sales (TTM)
27.02
Price To Book (MRQ)
3.35
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
19.01
LT Debt To Equity (MRQ)
17.74
Return on Investment (TTM)
-36.43
Return on Equity (TTM)
-33.17

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up